|licensing opportunity oncology new class|
|Written by Jean-Charles Brosse|
The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.
POC : In-vitro cytotoxicactivity on human cancer cells
A screening platform could be discussed as well
mobile : +33607832134
Read also at Pharmaceutical Licensing Network
Newer news items
|< Prev||Next >|
Jobline - Job opportunities published at Farmavita.Net
At the JobLine you can post your job vacancies or search for new job opportunities. We kindly invite all members to post their demand for full-time/part-time jobs, temporary needs, consulting support, project support, internship openings and other opportunities.If you are recruiter or just looking for job ..... find below important presentation which will describe you why are social networks are important to your career.